The short answer
No. NAD+ contains no amino acids and no peptide bonds. It is a dinucleotide (two nucleotides joined by a pyrophosphate bridge), which places it in the same chemical family as the building blocks of DNA and RNA, not proteins.
Key facts
- Amino acids
- None
- Peptide bonds
- None
- Actual class
- Dinucleotide coenzyme
- Related chemistry
- Nucleotides, DNA/RNA building blocks
- Molecular weight
- 663.4 Da
- Why it appears here
- Commercial category, not chemistry
What makes something a peptide
Amino acids joined by peptide bonds: amide linkages between one residue's carboxyl and the next one's amine. That is the whole definition. BPC-157 has fourteen such residues, KPV three, retatrutide thirty-nine. NAD+ has none, so it is not a peptide by any construction of the term.
What it is instead
A nucleotide is a nitrogenous base, a sugar and one or more phosphates. NAD+ is two of those (nicotinamide with ribose and a phosphate, adenine with ribose and a phosphate) connected through their phosphates. That is a dinucleotide, and it is the same structural grammar as ATP or a fragment of RNA.
Research material referenced
NAD+ 500mg, third-party HPLC tested
Why it sits in peptide catalogues
Commerce rather than chemistry. NAD+ is sold alongside research peptides because it reaches the same buyers and appears in overlapping literature, not because it belongs in the category. Glutathione has a better claim, since it is a true tripeptide, albeit an unusual one, while NAD+ has none at all.
What changes if you get this wrong
Most of the standard peptide handling logic. There is no sequence to verify, so identity confirmation is mass and chromatography against a known standard rather than sequence analysis. There are no proteases to worry about, but there is glycosidic and pyrophosphate hydrolysis, which peptide guidance never mentions. Purity means something different when there is no such thing as a deletion sequence.
The one thing that does carry over
Lyophilised, cold, dry and dark remains correct, but for different reasons. For a peptide it protects against hydrolysis of peptide bonds and oxidation of specific residues. For NAD+ it protects glycosidic and pyrophosphate bonds, which are if anything more labile in solution. Same instruction, different chemistry underneath.
Frequently asked questions
Is NAD+ a protein?
No. Proteins are chains of amino acids; NAD+ contains none.
Does peptide handling advice apply?
Only the general 'lyophilised, cold, dry, dark' instruction, and for different chemical reasons. Sequence verification, protease concerns and disulfide chemistry are all irrelevant.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More NAD+ articles
- NAD+ Molecular StructureTwo nucleotides, a pyrophosphate bridge, and a positive charge on the nicotinamide ring. Where the + in NAD+ comes from and what it does.
- The Membrane Problem: Why NAD+ Doesn't Get In663 Da with two negative charges does not cross a lipid bilayer. Why extracellular NAD+ is degraded before it arrives, and what that implies.
- NAD+ Precursors: Nicotinamide Riboside and NMNNR at 255.25 Da and NMN at 334.22 Da. What each is, how they enter the salvage pathway, and why almost all trial data uses them.
- NAD+ and Ageing: What Is Actually EstablishedTissue NAD+ falls with age, and Covarrubias 2020 identified a mechanism - senescent cells raising CD38. Whether restoring it helps is a separate question.
- What the Human Trials Actually FoundNADPARK, Orr 2024, Yoshino's Science paper and Yi 2023. Real randomised data - and uniformly on precursors rather than NAD+ itself.